🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

RecruitingNAAges 18 Years - anyAllAssistance Publique - Hôpitaux de Paris
NCT06457386 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Staphylococcus aureus is the most frequent cause of both healthcare-associated and community-acquired bloodstream infections worldwide. Infective endocarditis (IE) has been detected in 5-17% of cases and is a determinant of poor prognosis. The investigators developed a score (the VIRSTA score) based on patients' characteristics to rule out IE with high confidence (negative predictive value (NPV) above 99%) in patients with SAB. This score, with a cut-off of 3 has been externally validated by two international studies which have also established its high NPV. The 2023 European society of cardiology (ESC) guidelines state that echocardiography should be considered in all patients with Staphylococcus aureus bacteremia (SAB) using risk scores (including VIRSTA score) to guide the use or not of echocardiography. While recommended, the investigators think that VIRSTA score must be evaluated in

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria * Volunteers over 18 years of age; * Hospitalized with at least one blood culture positive for Staphylococcus aureus; * At the time of inclusion, negative control blood culture performed 48 hours after the first Staphylococcus aureus blood culture collection; * VIRSTA score \< 3; Exclusion criteria * Patient with catheter colonization without SAB, defined as positive blood cultures only through vascular access device specimen; * Patient referred to the hospital for the management of IE; * Contra indication to transthoracic echocardiography (TTE); * Echocardiography already performed before inclusion (TTE or TEE) for the current SAB; * Pregnancy; * Patient under guardianship or trusteeship. * Absence of written informed consent from the patient * No affiliation to social security (beneficiary or assignee) * Subject already involved in another interventional clinical research for which echocardiography must be done"
💊

What it tests

  • systematic echocardiography
  • no echocardiography arm
📍

Where

1 site
Bichat Claude Bernard Hospital
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy